London-based health tech firm Semble secures significant funding for international expansion.
- Outdated medical IT systems cost UK doctors millions in lost hours annually.
- Semble’s platform aims to enhance healthcare efficiency via automation and integration.
- The recent funding round was led by Mercia Ventures, with contributions from key investors.
- Semble’s innovative approach places it in a competitive position within the AI healthcare sector.
Semble, a prominent health technology company based in London, has successfully raised £11.6 million in a Series B funding round, a financial move that underscores its intention to broaden its reach into global markets. The investment is led by Mercia Ventures and supported by notable contributors such as Octopus Ventures, Smedvig Ventures, and Triple Point. This substantial funding highlights the confidence investors have in Semble’s capabilities and growth trajectory.
One of the significant challenges identified in the UK’s healthcare sector is the extensive time lost due to inefficient IT systems, with estimates suggesting over 13 million working hours are wasted annually. Semble addresses this pressing issue through its advanced clinical system, which replaces obsolete technologies with modern, efficient solutions that streamline operations.
The platform developed by Semble is designed to enhance healthcare delivery by automating routine tasks, ensuring secure exchanges of patient data, and offering seamless integration with various third-party systems. Christoph Lippuner, CEO of Semble, emphasises that the company’s mission is to amplify the effectiveness of healthcare professionals by alleviating their reliance on outdated systems, thereby allowing them to focus more on patient care.
Having been established in 2018 by Lippuner and Mikael Landau, Semble has witnessed a rapid rise, reflecting the founders’ in-depth understanding and experience in the healthcare industry. Prior to founding Semble, the duo sold their previous venture, Orogo, to Just Eat. This background, combined with the recent funding, positions Semble well to capitalise on emerging opportunities within the market.
Alex Gwyther from Mercia Ventures has acknowledged the significant growth potential within the healthcare market, while also pointing out the risks posed by the sector’s dependence on legacy systems. The strategic investment in Semble is viewed as a timely intervention to capture a substantial market share in an industry that is progressively leaning towards AI-driven solutions.
With substantial backing and a strategic focus on modernising healthcare IT, Semble is well-positioned to address inefficiencies and foster a more connected healthcare ecosystem.
